Results: 1875
Low C-Reactive Protein Alleles in Hepatocyte Nuclear Factor 1A Are Associated With an Increased Risk of Cardiovascular Disease.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2025, v. 110, n. 2, p. 592, doi. 10.1210/clinem/dgae602
- By:
- Publication type:
- Article
Association between glucagon-like peptide-1 receptor agonist use and progression of monoclonal gammopathy of uncertain significance to multiple myeloma among patients with diabetes.
- Published in:
- JNCI Cancer Spectrum, 2024, v. 8, n. 6, p. 1, doi. 10.1093/jncics/pkae095
- By:
- Publication type:
- Article
GLP-1 Mimetic Benefits Are Broad, New Study Finds, But Risks Can't Be Ignored.
- Published in:
- Patient Care (Online), 2025, p. 2
- By:
- Publication type:
- Article
Ethical Approaches to Limiting Overall Costs for Glucagon-Like Peptide-1 Receptor Agonists for Weight Management.
- Published in:
- 2025
- By:
- Publication type:
- Editorial
Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists.
- Published in:
- 2025
- By:
- Publication type:
- Opinion
Audio Highlights: December 14-20, 2024.
- Published in:
- JAMA: Journal of the American Medical Association, 2025, v. 333, n. 2, p. e2318486, doi. 10.1001/jama.2023.18486
- Publication type:
- Article
Managing cardiovascular events, hyperglycemia, and obesity in type 2 diabetes through microRNA regulation linked to glucagon-like peptide-1 receptor agonists.
- Published in:
- Diabetology & Metabolic Syndrome, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13098-025-01581-3
- By:
- Publication type:
- Article
A systematic review on the efficacy of GLP-1 receptor agonists in mitigating psychotropic drug-related weight gain.
- Published in:
- CNS Spectrums: The International Journal of Neuropsychiatric Medicine, 2024, v. 29, n. 5, p. 347, doi. 10.1017/S1092852924000531
- By:
- Publication type:
- Article
Glucagon‐like peptide 1 (GLP1) receptor agonists and risk for ischemic optic neuropathy: A meta‐analysis of randomised controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 1005, doi. 10.1111/dom.16076
- By:
- Publication type:
- Article
Survodutide, a glucagon receptor/glucagon‐like peptide‐1 receptor dual agonist, improves blood pressure in adults with obesity: A post hoc analysis from a randomized, placebo‐controlled, dose‐finding, phase 2 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 993, doi. 10.1111/dom.16052
- By:
- Publication type:
- Article
Future directions for quality of life research with second‐generation GLP‐1RAs for obesity.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 1018, doi. 10.1111/dom.16036
- By:
- Publication type:
- Article
The role of multimodality imaging in diabetic cardiomyopathy: a brief review.
- Published in:
- Frontiers in Endocrinology, 2025, p. 1, doi. 10.3389/fendo.2024.1405031
- By:
- Publication type:
- Article
Multiple sclerosis patients taking glucagon-like peptide-1 receptor (GLP-1) agonists: a single-institution retrospective cohort study of tolerability and weight loss.
- Published in:
- Neurological Sciences, 2025, v. 46, n. 1, p. 343, doi. 10.1007/s10072-024-07701-7
- By:
- Publication type:
- Article
Selective Colocalization of GHSR and GLP-1R in a Subset of Hypothalamic Neurons and Their Functional Interaction.
- Published in:
- Endocrinology, 2025, v. 166, n. 1, p. 1, doi. 10.1210/endocr/bqae160
- By:
- Publication type:
- Article
Repurposing Semaglutide and Liraglutide for Alcohol Use Disorder.
- Published in:
- JAMA Psychiatry, 2025, v. 82, n. 1, p. 94, doi. 10.1001/jamapsychiatry.2024.3599
- By:
- Publication type:
- Article
Preferences of Individuals With Obesity for Online Medical Consultation in Different Demand Scenarios: Discrete Choice Experiments.
- Published in:
- Journal of Medical Internet Research, 2024, v. 26, p. 1, doi. 10.2196/53140
- By:
- Publication type:
- Article
Renoprotective effect of liraglutide on diabetic nephropathy by modulation of Krüppel-like transcription factor 5 expression in rats.
- Published in:
- Journal of Pharmacy & Pharmacology, 2024, v. 76, n. 12, p. 1563, doi. 10.1093/jpp/rgae127
- By:
- Publication type:
- Article
Glucagon-like Peptide-1 Receptor Agonists and Diabetic Kidney Disease: From Bench to Bed-Side.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 24, p. 7732, doi. 10.3390/jcm13247732
- By:
- Publication type:
- Article
GLP-1 receptor agonists in patients with chronic kidney disease and either overweight or obesity.
- Published in:
- Clinical Kidney Journal, 2024, v. 17, p. ii19, doi. 10.1093/ckj/sfae296
- By:
- Publication type:
- Article
FDA Approves First Generic of Liraglutide Injection to Improve Glycemic Control in Patients with Type 2 Diabetes.
- Published in:
- Patient Care (Online), 2024, p. 6
- By:
- Publication type:
- Article
Effectiveness and Side Effect Incidence in a Real-World Digital Weight-Loss Service Using Compounded Semaglutide: A Retrospective Comparative Study.
- Published in:
- Obesities, 2024, v. 4, n. 4, p. 399, doi. 10.3390/obesities4040032
- By:
- Publication type:
- Article
Effects and mechanisms of long-acting glucagon-like peptide-1 receptor agonist semaglutide on microglia phenotypic transformation and neuroinflammation after cerebral ischemia/reperfusion in rats.
- Published in:
- Brain Circulation, 2024, v. 10, n. 4, p. 354, doi. 10.4103/bc.bc_38_24
- By:
- Publication type:
- Article
Gastrointestinal Safety Assessment of GLP-1 Receptor Agonists in the US: A Real-World Adverse Events Analysis from the FAERS Database.
- Published in:
- Diagnostics (2075-4418), 2024, v. 14, n. 24, p. 2829, doi. 10.3390/diagnostics14242829
- By:
- Publication type:
- Article
Biotechnology Revolution Shaping the Future of Diabetes Management.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 12, p. 1563, doi. 10.3390/biom14121563
- By:
- Publication type:
- Article
Discovery of a potential positive allosteric modulator of glucagon-like peptide 1 receptor through virtual screening and experimental study.
- Published in:
- Journal of Computer-Aided Molecular Design, 2019, v. 33, n. 11, p. 973, doi. 10.1007/s10822-019-00254-4
- By:
- Publication type:
- Article
Theranostic approaches in nuclear oncology: From bench to bed.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2019, v. 62, n. 10, p. 612, doi. 10.1002/jlcr.3787
- By:
- Publication type:
- Article
Exendin‐4 analogs in insulinoma theranostics.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2019, v. 62, n. 10, p. 656, doi. 10.1002/jlcr.3750
- By:
- Publication type:
- Article
New strategy for the treatment of type 2 diabetes mellitus with incretin-based therapy.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 1, p. 10, doi. 10.1007/s10157-012-0709-0
- By:
- Publication type:
- Article
Evaluating the utility of human glucagon-like peptide 1 receptor gene as a novel radionuclide reporter gene: a promising molecular imaging tool.
- Published in:
- Applied Microbiology & Biotechnology, 2019, v. 103, n. 3, p. 1311, doi. 10.1007/s00253-018-9562-8
- By:
- Publication type:
- Article
GLP1 Receptor Agonist Liraglutide Is an Effective Therapeutic Option for Perioperative Glycemic Control in Type 2 Diabetes within Enhanced Recovery After Surgery (ERAS) Protocols.
- Published in:
- European Surgical Research, 2018, v. 59, n. 5/6, p. 349, doi. 10.1159/000494768
- By:
- Publication type:
- Article
Effects of artemether on pancreatic islet morphology, islet cell turnover and α-cell transdifferentiation in insulin-deficient Glu<sup>CreERT2</sup>;ROSA26-eYFP diabetic mice.
- Published in:
- Journal of Pharmacy & Pharmacology, 2022, v. 74, n. 12, p. 1758, doi. 10.1093/jpp/rgac075
- By:
- Publication type:
- Article
STUDY OF THE INFLUENCE OF GLP-1 RECEPTOR AGONISTS ON THE METABOLIC ACTIVITY OF THE INTESTINAL MICROBIOTA IN PATIENTS WITH TYPE 2 DM.
- Published in:
- ScienceRise: Medical Science, 2023, v. 57, n. 6, p. 24, doi. 10.15587/2519-4798.2023.297535
- By:
- Publication type:
- Article
Mitochondrial Quality Control: Its Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
- Published in:
- Journal of Obesity & Metabolic Syndrome, 2023, v. 32, n. 4, p. 289, doi. 10.7570/jomes23054
- By:
- Publication type:
- Article
Side Effects Associated with Liraglutide Treatment for Obesity as Well as Diabetes.
- Published in:
- Journal of Obesity & Metabolic Syndrome, 2021, v. 30, n. 1, p. 12, doi. 10.7570/jomes20059
- By:
- Publication type:
- Article
The Effects of Hypoglycemic Agents on Non-alcoholic Fatty Liver Disease: Focused on Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists.
- Published in:
- Journal of Obesity & Metabolic Syndrome, 2019, v. 28, n. 1, p. 18, doi. 10.7570/jomes.2019.28.1.18
- By:
- Publication type:
- Article
The GLP-1 receptor agonists: what's all the (cardiovascular) hype about?
- Published in:
- SA Pharmaceutical Journal Incorporating Pharmacy Management, 2023, v. 90, n. 1, p. 18
- By:
- Publication type:
- Article
Comparison of desferrioxamine and NODAGA for the gallium-68 labeling of exendin-4.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2019, v. 4, n. 1, p. N.PAG, doi. 10.1186/s41181-019-0060-9
- By:
- Publication type:
- Article
Risk of Severe Hypoglycemia With Newer Second-line Glucose-lowering Medications in Older Adults With Type 2 Diabetes Stratified by Known Indicators of Hypoglycemia Risk.
- Published in:
- Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2023, v. 78, n. 12, p. 2426, doi. 10.1093/gerona/glad075
- By:
- Publication type:
- Article
Efficacy and Safety of Semaglutide, a Glucagon-Like Peptide-1 Receptor Agonist in Real-Life: A Case Series of Patients in Maintenance Incremental Hemodialysis.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer's disease.
- Published in:
- Acta Neuropathologica Communications, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40478-021-01180-z
- By:
- Publication type:
- Article
Polymorphisms of GLP-1 Receptor Gene and Response to GLP-1 Analogue in Patients with Poorly Controlled Type 2 Diabetes.
- Published in:
- Journal of Diabetes Research, 2015, v. 2015, p. 1, doi. 10.1155/2015/176949
- By:
- Publication type:
- Article
Regulation of glucose kinetics during exercise by the glucagon-like peptide-1 receptor.
- Published in:
- Journal of Physiology, 2012, v. 590, n. 20, p. 5245, doi. 10.1113/jphysiol.2012.234914
- By:
- Publication type:
- Article
Liraglutide as an effective tool for obesity management in type 1 diabetes -- case report.
- Published in:
- Romanian Journal of Diabetes Nutrition & Metabolic Diseases, 2023, v. 30, n. 2, p. 231, doi. 10.46389/rjd-2023-1299
- By:
- Publication type:
- Article
PROGRESE ÎN TERAPIA INJECTABILĂ ÎN DIABETUL ZAHARAT TIP 2.
- Published in:
- Romanian Journal of Diabetes Nutrition & Metabolic Diseases, 2020, v. 27, n. 1, p. 78
- By:
- Publication type:
- Article
The Effects of Exenatide on Serum CRP Levels in Patients with Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials.
- Published in:
- Romanian Journal of Diabetes Nutrition & Metabolic Diseases, 2020, v. 27, n. 1, p. 66, doi. 10.46389/rjd-2020-1011
- By:
- Publication type:
- Article
Diabetology & Cardiology: The Future is Now!
- Published in:
- Romanian Journal of Diabetes Nutrition & Metabolic Diseases, 2019, v. 26, n. 3, p. 221, doi. 10.2478/rjdnmd-2019-0022
- By:
- Publication type:
- Article
Innovative Therapies in Type 2 Diabetes: The Dream of the Future.
- Published in:
- Romanian Journal of Diabetes Nutrition & Metabolic Diseases, 2015, v. 22, n. 4, p. 341, doi. 10.1515/rjdnmd-2015-0040
- By:
- Publication type:
- Article
Dapagliflozin plus exenatide on patients with type 2 diabetes awaiting bariatric surgery in the DEXBASU study.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-07250-z
- By:
- Publication type:
- Article
Three-step matching algorithm to enhance between-group comparability and minimize confounding in comparative effectiveness studies.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-021-04014-z
- By:
- Publication type:
- Article
Development of an orally delivered GLP-1 receptor agonist through peptide engineering and drug delivery to treat chronic disease.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-01750-0
- By:
- Publication type:
- Article